Interactions between abacavir and Agenerase (amprenavir)
abacavir and amprenavir (Minor Drug-Drug)
Coadministration of amprenavir with abacavir results in increased blood levels of amprenavir. Average amprenavir levels increased 29% in the area under the time concentration curve during concomitant administration. The clinical significance is unknown. Patients receiving this combination should be monitored for altered efficacy and safety.